HUNTER HARRIS: Open Payments
NPI 1477251148 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 43 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $375 · 2025 $922
Food & beverage: $922
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $611 |
| Lilly USA, LLC | 2 | $54 |
| GENZYME CORPORATION | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Madrigal Pharmaceuticals | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
Products named: RINVOQ, SKYRIZI, LINZESS, OMVOH, DUPIXENT, VOQUEZNA, CREON, REZDIFFRA.
Industry payments across TX — which companies pay providers there.
